study on the efficacy, safety and pharmacokinetics of Debio 4326 in pediatric participants who are receiving gonadotropin-releasing hormone agonist therapy for central precocious puberty
Interventional
Central precocious puberty
Protocol Number: 23-2241
Principal Investigator